Skip to main content

Processa Pharmaceuticals, Inc PRE 14A, filed Oct 9, 2026

Processa Pharmaceuticals, Inc. (PCSA)

Processa Pharmaceuticals completed its merger with Vidya Therapeutics on July 28, 2026, raised approximately $200 million in a private placement, and is seeking approval for a 1-for-3 to 1-for-9 reverse stock split to support Nasdaq initial listing. AI summary

PRE 14A 2026-10-09 For: 2026-10-09
View Original
Added on October 18, 2026